CorMedix Inc.

CorMedix Inc. (ticker: CRMD) is an NASDAQ-listed pharmaceutical preparations company. DredgeCap's structured extraction of CRMD's SEC filings surfaces 5 active risk signals, including 2 auditor-change signals, 2 delisting/deregistration signals, and 1 late-filing signal. CRMD reported $127.43M in revenue and $38.60M for the period ending 2026-03-31, with operating cash flow of $42.38M. Cash and equivalents stood at $178.09M (up 168.7% year-over-year). Total assets of $815.64M exceed total liabilities of $378.59M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.